NVUS - Novus Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 565.7M
Enterprise Value 348.03M
Trailing P/E N/A
Forward P/E 1-4.75
PEG Ratio (5 yr expected) 10.07
Price/Sales (ttm)N/A
Price/Book (mrq)2.70
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-4.58

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Mar 31, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)-134.73%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -10.48M
Net Income Avi to Common (ttm)-13.34M
Diluted EPS (ttm)-2.0480
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)22.52M
Total Cash Per Share (mrq)2.39
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)14.84
Book Value Per Share (mrq)2.58

Cash Flow Statement

Operating Cash Flow (ttm)-16.33M
Levered Free Cash Flow (ttm)N/A

Trading Information

Stock Price History

Beta 0.00
52-Week Change 322.14%
S&P500 52-Week Change 313.38%
52 Week High 38.6100
52 Week Low 33.1200
50-Day Moving Average 36.7151
200-Day Moving Average 35.1288

Share Statistics

Avg Vol (3 month) 361.44k
Avg Vol (10 day) 37.69k
Shares Outstanding 59.41M
Float 4.72M
% Held by Insiders 122.84%
% Held by Institutions 151.63%
Shares Short (Jun 15, 2018) 415.2k
Short Ratio (Jun 15, 2018) 40.2
Short % of Float (Jun 15, 2018) 40.27%
Short % of Shares Outstanding (Jun 15, 2018) 40.16%
Shares Short (prior month May 15, 2018) 430.29k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/9
Last Split Date 3May 11, 2017